Average Co-Inventor Count = 8.33
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (20 from 125 patents)
2. Genentech, Inc. (7 from 3,221 patents)
3. Forma Tm, LLC (7 from 10 patents)
4. Valo Health, Inc. (4 from 29 patents)
5. Forma Tm2, Inc. (4 from 4 patents)
6. Other (3 from 832,680 patents)
7. Epix Pharmaceuticals, Inc. (3 from 14 patents)
8. E Ink Corporation (2 from 700 patents)
9. Novo Nordisk Healthcare Ag (1 from 88 patents)
10. Cytopathfinder, Inc. (1 from 2 patents)
11. Daimed (1 from 1 patent)
12. Daiamed, Inc. (1 from 1 patent)
47 patents:
1. 12336981 - Compounds and compositions for the inhibition of NAMPT
2. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
3. 12122778 - Activating pyruvate kinase R
4. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors
5. 11566013 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH1)
6. 11547701 - Compounds and compositions for the inhibition of NAMPT
7. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
8. 11479564 - Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
9. 11279687 - Compounds and compositions for the inhibition of NAMPT
10. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors
11. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
12. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
13. 10772874 - Compounds and compositions for the inhibition of NAMPT
14. 10696692 - Amido-benzyl sulfone and sulfoxide derivates
15. 10647695 - Compounds and compositions for the inhibition of NAMPT